Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05290818

Total Versus Robotic Assisted Unicompartmental Knee Replacement

The purpose of this research is to compare the functional outcomes of patients with end stage medial compartment OA of the knee undergoing a conventional mTKA to those undergoing rUKA and to assess the associated cost economics of such technology.

Recruiting

Interested in participating?

Request Info

Key information

Age range

50 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nicholas Clement

Edinburgh, Lothian, EH16 6SA, United Kingdom

Location status: Recruiting

Location contact

James T Patton, FRCS

CONTACT

[email protected]

(+44)131 536 1000

Nicholas D Clement, MD, PhD

CONTACT

[email protected]

(+44)131 536 1000

About this study

Unicompartmental knee arthroplasty (UKA) is an accepted surgical alternative to total knee arthroplasty (TKA) for patients with isolated medial compartmental joint disease with the potential advantages of accelerated recovery, improved functional outcomes and retention of anatomical knee kinematics. However, some surgeons continue to favour TKA over UKA due to a lower revision rate. The higher revision rates associated with UKA are thought to be primarily due to component malpositioning and postoperative limb malalignment.

Robotic-arm assisted (r)UKA offers a greater level of precision of component positioning compared to manual UKA and more recently the survivorship of rUKA has been shown to be greater than manual UKA. Early functional outcomes following robotic UKA appear to be better than those observed after manual TKA. Therefore, the benefits of UKA could potentially be enjoyed by the patient without the increased risk of revision when compared to TKA for those with medical compartment disease.

The primary aim of this study is to compare the early knee specific functional outcome of rUKA with manually performed (m)TKA when performed for patients with medial compartment osteoarthritis of the knee.

A single centre randomised control trial will be carried out powered to the Oxford knee score.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Listed for elective primary TKA for end stage medial compartment osteoarthritis
  • Intact anterior cruciate ligament
  • Full thickness and good quality lateral cartilage
  • Correctable intra-articular varus deformity and intact medial collateral ligament
  • American Society of Anesthesiologists (ASA) grades 1 and 2
  • Male or female, age 50 - 75 at the time of listing for surgery
  • Suitable candidate for a cruciate retaining TKA (Triathlon prosthesis) and a UKA

Exclusion criteria

  • Varus deformity of > 20 degrees
  • Fixed flexion of >10 degrees
  • Patient is unable to comply with the study protocol (incl. refusal for CT scan) or functional assessments
  • Female participants who are pregnant, lactating or planning pregnancy during the course of the study
  • Requires patella resurfacing or lateral compartment has significant OA
  • Inability to understand the patient information for the study, provide written informed consent or answer study questionnaires for cognitive or language reasons
  • Inflammatory disorder e.g. rheumatoid arthritis
  • Symptomatic foot, hip or spine pathology
  • Prior surgery (other than arthroscopy) or septic arthritis of the knee
  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study,

Treatment and study plan

MAKO™ Partial Knee Arthroplasty

Device

The robotic-arm will be used to position a partial knee arthroplasty.

Other names: Robotic-arm assisted partial knee arthroplasty

Triathlon (Stryker) Total Knee Arthroplasty

Device

Triathlon (Stryker) TKA with a cruciate retaining polyethylene insert.

Other names: Total Knee Replacement

Primary outcomes

  1. Oxford knee score

    Time frame: Baseline to 6 months

    Knee specific functional outcome measure. It consists of twelve questions assessed on a Likert scale with values from 0 to 4, to give a summative score. This is measured on a scale from 0 (worst) to 48 (best).

Secondary outcomes

  1. Oxford knee score and Activity and Participation Questionnaire

    Time frame: Baseline to 3, 6 and 12 months

    The Oxford knee score is a knee specific functional outcome measure. It consists of twelve questions assessed on a Likert scale with values from 0 to 4, to give a summative score. This is measured on a scale from 0 (worst) to 48 (best). The additional Activity and Participation Questionnaire is a higher functioning supplementary questionnaire consisting of a further eight questions scored 0 (worst) to 4 (best).

  2. Forgotten Joint Score

    Time frame: Baseline to 3, 6 and 12 months

    Knee specific functional outcome. It uses a five-point Likert response format, consisting of 12 equally weighted questions with the raw score transformed to range from zero (worst) to 100 (best) points.

  3. Patient satisfaction

    Time frame: 3, 6 and 12 months

    Patient satisfaction will be assessed following surgery by asking four questions with a different focus:

    i. "Overall how satisfied are you with the results of your knee replacement surgery?" ii. "How satisfied are you with the results of your knee replacement surgery for improving your ability to do housework or yard work (such as cooking, cleaning, or gardening and raking leaves)?" iii. "How satisfied are you with the results of your knee replacement surgery for improving your ability to do recreational activities (such as taking walks, swimming, bicycling, playing golf, dancing, going out with friends)?" iv. "How satisfied are you with the results of your knee replacement surgery for relieving your pain?" The response to each question will be recorded using a four point Likert scale: very satisfied, somewhat satisfied, somewhat dissatisfied, and very dissatisfied.

  4. EQ-5D-3L

    Time frame: Baseline to 3, 6 and 12 months

    Quality of life will be assessed using the EQ-5D-3L general health questionnaire which evaluates five domains (-5D), which include: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. This is a two page questionnaire that consists of five dimensions, with the responses recorded at three levels (3L) of severity (no problems; some problems or extreme problems). The utility index is on a scale of -0.594 to 1, where 1 represents perfect health and a negative value represents a state perceived as worse than death.

    The second page consists of a standard vertical 20cm visual analogue scale (EQ-5D VAS) which is transformed to a scale of 0 (worst) to 100 (best) measuring current health-related quality of life. Each patient's health state, derived from the EQ-5D, will be measured before and after their surgery to determine the change in their health gain or loss after their knee replacement surgery.

  5. Range of movement

    Time frame: Baseline to 3, 6 and 12 months

    A goniometer will be used to measure range of movement by a blinded researcher prior to surgery (baseline), at discharge (immediately post surgery prior to discharge home) and at review appoints. Three measurements will be recorded for extension and flexion of the knee and an average will be documented.

  6. Cost effectiveness

    Time frame: Baseline to 3, 6 and 12 months, and projected for the patients lifetime

    Cost utility analysis will be undertaken to establish the incremental cost effectiveness ratio (ICER). Each patient's health state, derived from the EQ-5D, will be measured before and after their surgery to determine the change in their health gain or loss after their knee replacement surgery. The health state will then be multiplied by the time spent in that state to derive the QALYs gained or lost. The cost per QALY will then be calculated by dividing the cost of the procedure by the QALYs gained after total knee arthroplasty (intervention). A health service resource use questionnaire will be completed by the patient at the 3, 6 and 12 month research assessment. The questionnaire collects data on primary, secondary and community care and associated with the knee replacement over the previous months. Inpatient and surgical data will be collected on the case report forms (CRF's) and complications will be recorded at each visit.

  7. Knee stability and power

    Time frame: Baseline to 3, 6 and 12 months

    Knee stability (stress testing) and power (power rig) will be measured. A stress will be applied to the knee and the joint space opening will be measured using an ultrasound probe which will be used as a marker of knee stability. The power of the knee joint will be assessed using a standardise power rig Specific assessment of the patient's power output will be evaluated by a Leg Extensor Power Rig (Nottingham, UK), well validated for use with this population group.

  8. Patient expectation pre-operative and fulfilment

    Time frame: Baseline to 3, 6 and 12 months

    The Hospital of Special Surgery Expectation questionnaire is a validated measure of patient pre-operative expectations of surgery. The level of patient expectation is indicated on a 5 point Likert scale as 'very important', 'somewhat important', 'a little important', 'I do not expect this' or 'this does not apply to me'. After surgery patients will complete a similar expectation questionnaire, but are asked whether the same expectations had been fulfilled, which again is assessed on a 5 point Likert scale as: 'greatly', 'a lot', 'a little', 'I did not expect this' or 'this did not apply to me'.

Study contacts

Contact information is provided by the study sponsor or research team.

James T Patton, FRCS

CONTACT

[email protected]

+44 131 536 1000

Nicholas D Clement, MD, PhD

CONTACT

[email protected]

+44 131 536 1000

Sponsors and collaborators

Lead sponsor

NHS Lothian

Other Gov

Registry information

Official study title

Total Versus Robotic Assisted Unicompartmental Knee Replacement (TRAKER) for Medial Compartment Osteoarthritis: Randomised Controlled Trial

Acronym: TRAKER

Important dates

Study start
2024
Primary completion
2026
Study completion
2027
First posted
Mar 22, 2022
Registry last updated
Feb 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.